Extended anticoagulation after venous thromboembolism: should it be done? | Zendy

Fernandes Caio J. | Zendy; Calderaro Daniela | Zendy; Piloto Bruna | Zendy; Hoette Susana | Zendy; Jardim Carlos Vianna Poyares | Zendy; Souza Rogério | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Extended anticoagulation after venous thromboembolism: should it be done?

Author(s) -

Fernandes Caio J.,

Calderaro Daniela,

Piloto Bruna,

Hoette Susana,

Jardim Carlos Vianna Poyares,

Souza Rogério

Publication year - 2019

Publication title -

therapeutic advances in respiratory disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.022

H-Index - 37

eISSN - 1753-4666

pISSN - 1753-4658

DOI - 10.1177/1753466619878556

Subject(s) - medicine , venous thromboembolism , intensive care medicine , disease , epidemiology , pulmonary embolism , thrombosis , surgery

Most physicians understand venous thromboembolism (VTE) to be an acute and time-limited disease. However, pathophysiological and epidemiological data suggest that in most patients VTE recurrence risk is not resolved after the first 6 months of anticoagulation. Recurrence rates are high and potentially life-threatening. In these cases, it would make sense to prolong anticoagulation for an undetermined length of time. However, what about the bleeding rates, induced by prolonged anticoagulation? Would they not outweigh the benefit of reducing the VTE recurrent risk? How long should anticoagulation be continued, and should all patients suffering from VTE be provided with extended anticoagulation? This review will address the most recent data concerning extended anticoagulation in VTE secondary prophylaxis. The reviews of this paper are available via the supplementary material section.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research